Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in 2023: GlobalData Read more
US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia Read more
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more